The RIAA has dropped its case against Chicagoan Paul Wilke, with the two parties moving to dismiss the case with prejudice in federal court late last week. Elektra v. Wilke was noteworthy in that the defendant vigorously contested all of the RIAA's allegations, moving for summary judgment against the record label last month.

Wilke had been accused of the usual malfeasance by the RIAA: sharing music over a P2P network. Instead of settling the suit as many others have done, Wilke denied any wrongdoing. He claimed that he was not the "Paule Wilke" named in the complaint, had never used any filesharing applications, and that he did not own any of the songs reportedly flagged by Media Sentry.

Wilke's argument that the RIAA did not have enough evidence for itsMeeting the therapeutic challenge of the patient with osteoarthritis.
To discuss the diagnosis of osteoarthritis and the efficacy of available pharmacologic and nonpharmacologic treatment options. Published reports on the diagnosis and treatment of osteoarthritis were identified through a MEDLINE search of English-language journal articles using a focused title search for the keywords acetaminophen, nonsteroidal anti-inflammatory, COX-2 nonsteroidal, opioids, capsaicin, tramadol, glucosamine, hyaluronic acid, and osteoarthritis and by reviewing the bibliographies of selected reviews. The American College of Rheumatology (ACR) guidelines, as updated in September 2000, for the treatment of osteoarthritis of the hip and knee were analyzed with appropriate references to clinical and scientific studies, review articles, and other published guidelines. Each patient's medical history and level of pain should decide the most appropriate treatment. Nonpharmacologic therapies should always